frovatriptan succinate

Drug ingredient

CAS 158930-17-7

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

Molecular structure of 158930-17-7
1 H₂O
US productionNot reported
Top sourceNo public record

This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.

Why supply is unknown

Where It Comes From

EPA and Census publish no US supply data for this chemical.

8 FDA-registered drug labelers
Alivus Life Sciences Limited
Almac Pharma Services Limited
Amneal Pharmaceuticals NY LLC
Glenmark Pharmaceuticals Inc., USA
Ingenus Pharmaceuticals, LLC
MYLAN LABORATORIES LIMITED
Sionc Pharmaceutical Private Limited
Viyash Life Sciences Private Limited

Why It Matters

Sectors
Health
Downstream Uses

Appears in 2 drug and cosmetic product listings (FDA).

  • •Frovatriptan
  • •frovatriptan succinate
FDA Shortage Status
No Shortage
Shortage History
  • to be discontinued

    Frovatriptan Succinate Tablet

    Shortage listed since November 12, 2025

See all current drug shortages

Chemical Identity

CAS158930-17-7
PubChem CID152943
DTXSIDDTXSID2049056
FormulaC18H25N3O6
Mol. Weight379.4 g/mol
SMILESCNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N.C(CC(=O)O)C(=O)O.O

Data Sources

Brief citations

frovatriptan succinate (CAS 158930-17-7) https://chemicalindependence.com/chemical/158930-17-7/ PubChem: 152943. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/152943 FDA National Drug Code directory: CAS 158930-17-7. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA Drug Shortages: CAS 158930-17-7. Retrieved 2026-10-04. https://www.accessdata.fda.gov/scripts/drugshortages/